Are clarithromycin, azithromycin and their analogues effective in the treatment of COVID19

Creative Commons License

Gedikli M. A., Tuzun B., Aktas A., Sayin K., Ataseven H.

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.122, sa.2, ss.101-110, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 122 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4149/bll_2021_015
  • Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.101-110
  • Anahtar Kelimeler: SARS-CoV-2, RNA-dependent RNA polymerase, Azithromycin, Clarithromycin, COVID19, BORON COMPLEXES, MOLECULAR DOCKING, IN-VITRO, SOLUBILITY, PROTEIN
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

BACKGROUND: SARS-CoV-2, which started in Wuhan and later affected the whole world, is the most important disease of the world today. Many ways to inhibit SARS-CoV-2 virus are sought to prevent the spread of this virus. Azithromycin and clarithromycin are considered for the treatment of the SARS-CoV-2 virus, which has a high similarity to previous colonic diseases.